122 related articles for article (PubMed ID: 24698651)
21. Valproic acid effects in the hippocampus and prefrontal cortex in an animal model of post-traumatic stress disorder.
Wilson CB; McLaughlin LD; Ebenezer PJ; Nair AR; Francis J
Behav Brain Res; 2014 Jul; 268():72-80. PubMed ID: 24675160
[TBL] [Abstract][Full Text] [Related]
22. Affective and anxiety comorbidity in post-traumatic stress disorder treatment trials of sertraline.
Brady KT; Clary CM
Compr Psychiatry; 2003; 44(5):360-9. PubMed ID: 14505296
[TBL] [Abstract][Full Text] [Related]
23. Models of PTSD and traumatic stress: the importance of research "from bedside to bench to bedside".
Ursano RJ; Li H; Zhang L; Hough CJ; Fullerton CS; Benedek DM; Grieger TA; Holloway HC
Prog Brain Res; 2008; 167():203-15. PubMed ID: 18037016
[TBL] [Abstract][Full Text] [Related]
24. Animal models in translational studies of PTSD.
Daskalakis NP; Yehuda R; Diamond DM
Psychoneuroendocrinology; 2013 Sep; 38(9):1895-911. PubMed ID: 23845512
[TBL] [Abstract][Full Text] [Related]
25. A modified single-prolonged stress model for post-traumatic stress disorder.
Wang W; Liu Y; Zheng H; Wang HN; Jin X; Chen YC; Zheng LN; Luo XX; Tan QR
Neurosci Lett; 2008 Aug; 441(2):237-41. PubMed ID: 18577419
[TBL] [Abstract][Full Text] [Related]
26. Identification of gene markers based on well validated and subcategorized stressed animals for potential clinical applications in PTSD.
Zhang L; Zhou R; Xing G; Hough CJ; Li X; Li H
Med Hypotheses; 2006; 66(2):309-14. PubMed ID: 16216432
[TBL] [Abstract][Full Text] [Related]
27. [Treatment of post-traumatic stress syndrome].
Lepine JP; Darves-Bornoz JM
Acta Psychiatr Belg; 1993; 93(3):121-35. PubMed ID: 8030427
[TBL] [Abstract][Full Text] [Related]
28. [Post-traumatic stress disorder and acute stress disorder].
Attal J
Rev Prat; 2009 Sep; 59(7):969-72. PubMed ID: 19839469
[TBL] [Abstract][Full Text] [Related]
29. Developing zebrafish models relevant to PTSD and other trauma- and stressor-related disorders.
Stewart AM; Yang E; Nguyen M; Kalueff AV
Prog Neuropsychopharmacol Biol Psychiatry; 2014 Dec; 55():67-79. PubMed ID: 25138994
[TBL] [Abstract][Full Text] [Related]
30. The endocannabinoid system and Post Traumatic Stress Disorder (PTSD): From preclinical findings to innovative therapeutic approaches in clinical settings.
Berardi A; Schelling G; Campolongo P
Pharmacol Res; 2016 Sep; 111():668-678. PubMed ID: 27456243
[TBL] [Abstract][Full Text] [Related]
31. Prevention of posttraumatic stress disorder.
Sones HM; Thorp SR; Raskind M
Psychiatr Clin North Am; 2011 Mar; 34(1):79-94. PubMed ID: 21333841
[TBL] [Abstract][Full Text] [Related]
32. Evidence-based pharmacological treatment of anxiety disorders, post-traumatic stress disorder and obsessive-compulsive disorder: a revision of the 2005 guidelines from the British Association for Psychopharmacology.
Baldwin DS; Anderson IM; Nutt DJ; Allgulander C; Bandelow B; den Boer JA; Christmas DM; Davies S; Fineberg N; Lidbetter N; Malizia A; McCrone P; Nabarro D; O'Neill C; Scott J; van der Wee N; Wittchen HU
J Psychopharmacol; 2014 May; 28(5):403-39. PubMed ID: 24713617
[TBL] [Abstract][Full Text] [Related]
33. Considering future pharmacotherapy for PTSD.
Friedman MJ; Bernardy NC
Neurosci Lett; 2017 May; 649():181-185. PubMed ID: 27890743
[TBL] [Abstract][Full Text] [Related]
34. Post-traumatic stress disorder (PTSD) treatment experience in Bedford East - audit and reaudit.
Middleton E; Agius M; Zaman R
Psychiatr Danub; 2011 Sep; 23 Suppl 1():S104-9. PubMed ID: 21894114
[TBL] [Abstract][Full Text] [Related]
35. Modeling PTSD in the zebrafish: are we there yet?
Caramillo EM; Khan KM; Collier AD; Echevarria DJ
Behav Brain Res; 2015 Jan; 276():151-60. PubMed ID: 24821404
[TBL] [Abstract][Full Text] [Related]
36. [Posttraumatic stress disorder: an evidence-based approach].
Soares BG; de Lima MS
Braz J Psychiatry; 2003 Jun; 25 Suppl 1():62-6. PubMed ID: 14523514
[TBL] [Abstract][Full Text] [Related]
37. How could MDMA (ecstasy) help anxiety disorders? A neurobiological rationale.
Johansen PØ; Krebs TS
J Psychopharmacol; 2009 Jun; 23(4):389-91. PubMed ID: 19273493
[TBL] [Abstract][Full Text] [Related]
38. Modeling specific phobias and posttraumatic stress disorder in rodents: the challenge to convey both cognitive and emotional features.
Berardi A; Trezza V; Campolongo C
Rev Neurosci; 2012; 23(5-6):645-57. PubMed ID: 23006899
[TBL] [Abstract][Full Text] [Related]
39. [Selective stimulations and lesions of the rat brain nuclei as the models for research of the human sleep pathology mechanisms].
Šaponjić J
Glas Srp Akad Nauka Med; 2011; (51):85-97. PubMed ID: 22165729
[TBL] [Abstract][Full Text] [Related]
40. Emerging roles for atypical antipsychotics in chronic post-traumatic stress disorder.
Hamner MB; Robert S
Expert Rev Neurother; 2005 Mar; 5(2):267-75. PubMed ID: 15853496
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
